csirt@kutim:~/threat-intel/cve/CVE-2024-6563

Katalog CVE

CVSS 6.7 · Medium EPSS 0,21%

Kerentanan Buffer Copy without Checking Size of Input ('Classic Buffer Overflow') pada renesas arm-trusted-firmware. Skor CVSS 3.1 6.7 (Medium) menurut NVD.

Deskripsi (NVD)

Buffer Copy without Checking Size of Input ('Classic Buffer Overflow') vulnerability in Renesas arm-trusted-firmware allows Local Execution of Code. This vulnerability is associated with program files https://github.Com/renesas-rcar/arm-trusted-firmware/blob/rcar_gen3_v2.5/drivers/renesas/common/io/i... https://github.Com/renesas-rcar/arm-trusted-firmware/blob/rcar_gen3_v2.5/drivers/renesas/common/io/io_rcar.C . In line 313 "addr_loaded_cnt" is checked not to be "CHECK_IMAGE_AREA_CNT" (5) or larger, this check does not halt the function. Immediately after (line 317) there will be an overflow in the buffer and the value of "dst" will be written to the area immediately after the buffer, which is "addr_loaded_cnt". This will allow an attacker to freely control the value of "addr_loaded_cnt" and thus control the destination of the write immediately after (line 318). The write in line 318 will then be fully controlled by said attacker, with whichever address and whichever value ("len") they desire.

Rincian

Terbit di NVD
8 Juli 2024
Terakhir diubah
17 Juni 2026
Status NVD
Modified
CVSS 3.1
6.7 (Medium), sumber NVD
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-120: Buffer Copy without Checking Size of Input ('Classic Buffer Overflow')
CWE-123: Write-what-where Condition
EPSS (30 hari)
0,21% peluang dieksploitasi; lebih tinggi dari 10,5% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
renesas arm-trusted-firmware Semua versi

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.